Minhee Sung, MD

Yale/VA Connecticut Internal & Addiction Med Clinician | @MIT @yalemed @The_BMC grad | Tweets are my own

[Yale Program in Addiction Medicine @YaleADM]

Starting in less than 1 hour! We hope you'll join us today along with @YaleHealthSIG for "Substance Use and Addiction in Older Adults."

🔗 https://t.co/34NCCmqoDt

[Yale Program in Addiction Medicine @YaleADM]

Few PWID are taking #HIV #PrEP. A newly published study from @sung_minhee, @yalediablo et al explores avenues for reaching PWID in #opioid treatment & #harmreduction programs + using contingency management to promote sustained PrEP adherence. https://t.co/zby5WwG3zG

[Yale Program in Addiction Medicine @YaleADM]

Are you at #APHA2022 today? Don't miss @sung_minhee & @WillCBecker1 presenting in just 15 minutes! cc: @Drbob52

[Minhee Sung, MD @sung_minhee]

We found that buprenorphine prescribers highly used virtual care to provide medications to treat opioid use disorder during the COVID-19 pandemic and that many of these prescribers would like to continue providing care virtually even post-pandemic!

[Minhee Sung, MD @sung_minhee]

Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers https://t.co/PKX3gM8SnR

Published in @JAM_ASAM in a collaborative effort led by @AAAP1985

[Yale Internal Medicine @YaleIMed]

Polypharmacy—taking of 5 different medications concurrently—is a well-known cause of frailty, but little is known about persons living with HIV who are on antiretroviral therapy & other medications.

Learn more: https://t.co/56RqUen3Ek

@sung_minhee @YaleMed @YalePCCSM @YaleADM

[American Academy of Pain Medicine (AAPM) @AmerAcadPainMed]

Make sure to check out this free & relevant study done by @DrSaraEdmond, Sophia Currie, Amanda Gehrke, PhD, Caroline G Falker, MD, @sung_minhee, @audsnotevens, @ellenedensmd, and William C Becker, MD @YaleADM @YaleMed #painmedicine

[Paul Joudrey @PaulJoudreyMD]

Canadian clinics provided more timely access to methadone for opioid use disorder than highly regulated US opioid treatment programs (methadone clinics) - And COVID-19 reduced the number of available clinics in both nations @JAMANetworkOpen @YaleADM

[Society of General Internal Medicine (SGIM) @SocietyGIM]

Join us in congratulating @AdamMarkovitz @sung_minhee & Michael Sun the winners of the SGIM 21 Mack Lipkin, Sr. Associate Member Awards! This award is presented to scientific presentations considered outstanding by students, residents & fellows at #SGIM21 https://t.co/Dt2tEsaJgG

[Yale Program in Addiction Medicine @YaleADM]

Congratulations to @sung_minhee & team, among winners of the 2021 @SocietyGIM Mack Lipkin Sr., Associate Member Award for most outstanding abstract! "The Association of Prescribed Opioids & Incident Cardiovascular Disease in the Veterans Aging Cohort Study."

[Yale Program in Addiction Medicine @YaleADM]

Don't miss these @YaleADM faculty members and their presentations today @SocietyGIM #SGIM21 Day 3!

[Minhee Sung, MD @sung_minhee]

Excited to present our work studying the association between prescription opioids and cardiovascular disease in the veterans aging cohort study at #SGIM21 as a Lipkin Award Finalist today! @SocietyGIM

[Alice Lü-Culligan, MD, PhD @aliceluculligan]

Thinking of all the women left anxious and confused about the vaccine, who deserve so much more from us.

And eternally grateful to the two women in particular @randihepstein and @VirusesImmunity who believed in this message and in me. Mentorship matters.

https://t.co/E4uWPimLEf

[Ryan Chippendale MD @RZChipMD]

Beautiful piece written by 2 of our amazing @BMCimRES @The_BMC residents @iniya_rajendran @StephVanDecker1. So #bmcproud of you both!

The view from two residents inside an ICU’s pandemic crew: Covid brain, relentless sorrow, and... https://t.co/o9DcNSsJkk via @statnews

[Minhee Sung, MD @sung_minhee]

Excited to pitch our naloxone (Narcan) autoinjector device as finalists for the $10,000 Startup @Yale Rita Wilson Prize (virtually of course)!

[Jessica Taylor, MD @JessicaTaylorMD]

“interested” in their care. Anyone who finds and makes it into a buprenorphine bridge clinic is very interested in reducing overdose risk, managing withdrawal, and/or OUD recovery. Missing other clinic visits likely not an issue of interest but rather of high barrier care (2/2)

[Jessica Taylor, MD @JessicaTaylorMD]

Saw a pt in bridge clinic recently who needed PCP referral for SUD/Psych program. We called office together and were told pt has missed visits and “must not be interested in her health.” We have to get away from this narrative that people with SUD and other barriers are not (1/x)

[Sumeet Pawar, MD @sumeetpawar]

This is very relevant to today’s #HealthTech session titled ‘How can the electronic health record improve healthcare?’ 3-4 pm

A very important question with wide reaching consequences for all - patients, doctors, hospitals, payers.

@hmkyale @jspertus

#AHA19
@AHAMeetings

[Sumeet Pawar, MD @sumeetpawar]

Tips for #AHAearlycareer faculty for publishing

• Discuss authorship early
• Browse journal content to assess fit
• Verify publisher credentials
• Consider journal finders
• Track impact metrics
• Altmetrics complements citations
• Get an ORCID

@AHAMeetings #AHA19

[Minhee Sung, MD @sung_minhee]

@ManeeshJuneja @TomSequist Great question. I think addressing SDOH will require a multi-pronged approach involving policy, tech, etc. For example, tech can help pts find existing resources that address homelessness, access to affordable fresh produce and policy can create more of these resources!

[Minhee Sung, MD @sung_minhee]

We have to remember that current medical technologies were not built to address social determinants of health (SDH). Instead of adding on to existing tech we really should build from the ground up with SDH at the focus. Great point by @TomSequist #Connect2Health